Mersana Therapeutics (MRSN) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.52
-0.4
-0.28
-0.16

Details

Expected EPS
-0.160169
Actual EPS
-0.16
Surprise EPS
0
Surprise Percent
+0.11%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.16 per share for Q4 2023.

0 Comments

Share your thoughts